There are very few reliable blood tests that can actually help predict the possibility of developing cancer as well as monitoring the progress through specific treatments.
Dr. Emil Schandl, a clinical biochemist and oncobiologist has developed a battery of blood tests designed to predict the risk of developing cancer long before any symptoms may occur. It is also an excellent way to monitor your progress through a course of treatment, toxic or non-toxic.
Who should order this test? Anyone who has concerns about developing cancer because of family history, exposure to chemicals and radiation or anyone showing any type of suspicious symptoms.
The beauty of the Cancer profile is that it combines a number of tests, not just 1 or 2 markers.
Together, this profile provides an impressive level of accuracy of 90%-93%.
Here is a list of the markers that the Cancer Profile includes:
HCGx3: human chorionic gonadotropin, IRMA & IMM, the pregnancy hormone and “malignancy hormone,” by Dr. Schandl
HCG (IRMA): a highly sensitive test for the intact HCG molecule
HCG (IMM): a sensitive test for the nicked beta subunit, beta subunit, beta core, nicked dimer and the intact HCG dimer
*HCG-Urine: a quantitative assay is now available that may give similar results as the HCG (IMM). However, it is not recommended to substitute serum for urine sample. * Can be ordered with or with out the Cancer Profile©.
PHI: phosphohexose isomerase, the enzyme that regulates anaerobic metabolism and is a neurokine, the Autocrine Motility Factor (AMF, malignancy promoter).
CEA: carcinoembryonic antigen, a cancer antigen.
TSH: thyroid stimulating hormone, can detect high or low thyroid activity, (when it is low the thyroid is over active and when it is high the thyroid is under active). Many cancer patients and those who are developing cancer are hypothyroid.
DHEA-S: dehydroepiandrosterone sulfate, the adrenal “anti-stress, pro-immunity, longevity hormone,” according to Dr. Schandl. Most cancer patients, and those who are developing cancer, have low serum DHEA levels.
The HCGs, PHI and CEA are the actual tumor markers or cancer markers. The other three are peripherally but intimately related.
HCG can be elevated in an existing cancer, stress that is leading to cancer, or in a developing cancer in some instances as many as 10-12 years before an actual tumor could be detected by any other method.
PHI can be elevated in a developing cancer, existing cancer, or an acute heart, liver, muscle disease, acute hypothyroidism or acute viral infection.
CEA test was originally developed to monitor colorectal cancers. It is actually an excellent non-organ specific cancer marker. It can be elevated in most types of cancers.
It must be noted that, even though the CA Profile© is the best of its kind, giving positive results in 90-93% established cancer cases, a pathologist does the final diagnosis on tissue/cell biopsy analysis. The CA Profile© is an excellent adjunct.
(Much of this information was taken from an article written by Dr. Schandl.)
[hilight color=”FFFF00″]Order this test in October and receive a FREE CA 15-3 Breast Tumor Marker with your purchase of the Cancer Profile.[/hilight]